84 related articles for article (PubMed ID: 8149975)
1. Intracerebral infusion of (+)-AJ76 and (+)-UH232: effects on dopamine release and metabolism in vivo.
Waters N; Hansson L; Löfberg L; Carlsson A
Eur J Pharmacol; 1994 Jan; 251(2-3):181-90. PubMed ID: 8149975
[TBL] [Abstract][Full Text] [Related]
2. The dopamine D3 receptor and autoreceptor preferring antagonists (+)-AJ76 and (+)-UH232; a microdialysis study.
Waters N; Lagerkvist S; Löfberg L; Piercey M; Carlsson A
Eur J Pharmacol; 1993 Sep; 242(2):151-63. PubMed ID: 8253112
[TBL] [Abstract][Full Text] [Related]
3. Effects of intrastriatal infusion of D2 and D3 dopamine receptor preferring antagonists on dopamine release in rat dorsal striatum (in vivo microdialysis study).
Sotnikova TD; Gainetdinov RR; Grekhova TV; Rayevsky KS
Pharmacol Res; 2001 Mar; 43(3):283-90. PubMed ID: 11401421
[TBL] [Abstract][Full Text] [Related]
4. Antagonism of cocaine's pharmacological effects by the stimulant dopaminergic antagonists, (+)-AJ76 and (+)-UH232.
Piercey MF; Lum JT; Hoffmann WE; Carlsson A; Ljung E; Svensson K
Brain Res; 1992 Aug; 588(2):217-22. PubMed ID: 1393576
[TBL] [Abstract][Full Text] [Related]
5. Effects on locomotor activity after local application of (+)-UH232 in discrete areas of the rat brain.
Kling-Petersen T; Ljung E; Waters N; Svensson K
J Neural Transm (Vienna); 1996; 103(3):331-41. PubMed ID: 8739844
[TBL] [Abstract][Full Text] [Related]
6. The 5-HT1A receptor antagonist (S)-UH-301 decreases dopamine release in the rat nucleus accumbens and striatum.
Nomikos GG; Arborelius L; Höök BB; Hacksell U; Svensson TH
J Neural Transm (Vienna); 1996; 103(5):541-54. PubMed ID: 8811500
[TBL] [Abstract][Full Text] [Related]
7. [Regulation of liberation and metabolism of dopamine in the dorsal striatum of free-living rats: the role of D2- and D3-dopamine autoreceptors].
Gaĭnetdinov RR; Sotnikova TD; Grekhova TV; Raevskiĭ KS
Dokl Akad Nauk; 1994 Aug; 337(6):821-3. PubMed ID: 7981645
[No Abstract] [Full Text] [Related]
8. Dopamine D3-preferring ligands act at synthesis modulating autoreceptors.
Aretha CW; Sinha A; Galloway MP
J Pharmacol Exp Ther; 1995 Aug; 274(2):609-13. PubMed ID: 7636720
[TBL] [Abstract][Full Text] [Related]
9. In vivo evidence for preferential role of dopamine D3 receptor in the presynaptic regulation of dopamine release but not synthesis.
Gainetdinov RR; Sotnikova TD; Grekhova TV; Rayevsky KS
Eur J Pharmacol; 1996 Jul; 308(3):261-9. PubMed ID: 8858296
[TBL] [Abstract][Full Text] [Related]
10. Effects of repeated administration of the preferential dopamine autoreceptor antagonist, (+)-AJ76, on locomotor activity and brain DA metabolism in the rat.
Kullingsjö H; Carlsson A; Svensson K
Eur J Pharmacol; 1991 Dec; 205(3):241-6. PubMed ID: 1817961
[TBL] [Abstract][Full Text] [Related]
11. Striatal dopamine metabolism increases during long-term haloperidol administration in rats but shows tolerance in response to acute challenge with raclopride.
See RE
Neurosci Lett; 1991 Aug; 129(2):265-8. PubMed ID: 1720879
[TBL] [Abstract][Full Text] [Related]
12. Regulation of dopamine release and metabolism in rat striatum in vivo: effects of dopamine receptor antagonists.
Rayevsky KS; Gainetdinov RR; Grekhova TV; Sotnikova TD
Prog Neuropsychopharmacol Biol Psychiatry; 1995 Dec; 19(8):1285-1303. PubMed ID: 8868210
[TBL] [Abstract][Full Text] [Related]
13. Dopamine D(3) receptors modulate evoked dopamine release from slices of rat nucleus accumbens via muscarinic receptors, but not from the striatum.
Yamada S; Harano M; Annoh N; Tanaka M
J Pharmacol Exp Ther; 1999 Dec; 291(3):994-8. PubMed ID: 10565816
[TBL] [Abstract][Full Text] [Related]
14. The role of dopamine D3 compared with D2 receptors in the control of locomotor activity: a combined behavioural and neurochemical analysis with novel, selective antagonists in rats.
Millan MJ; Seguin L; Gobert A; Cussac D; Brocco M
Psychopharmacology (Berl); 2004 Jul; 174(3):341-57. PubMed ID: 14985929
[TBL] [Abstract][Full Text] [Related]
15. Prevention by (+/-)-8-hydroxy-2-(di-n-propylamino)tetralin of both catalepsy and the rises in rat striatal dopamine metabolism caused by haloperidol.
Andersen HL; Kilpatrick IC
Br J Pharmacol; 1996 May; 118(2):421-7. PubMed ID: 8735647
[TBL] [Abstract][Full Text] [Related]
16. The involvement of dopamine D2 receptors, but not D3 or D4 receptors, in the rewarding effect of brain stimulation in the rat.
Nakajima S; Patterson RL
Brain Res; 1997 Jun; 760(1-2):74-9. PubMed ID: 9237520
[TBL] [Abstract][Full Text] [Related]
17. Dopamine D2 and D3 receptor preferring antagonists differentially affect striatal dopamine release and metabolism in conscious rats.
Gainetdinov RR; Grekhova TV; Sotnikova TD; Rayevsky KS
Eur J Pharmacol; 1994 Aug; 261(3):327-31. PubMed ID: 7813556
[TBL] [Abstract][Full Text] [Related]
18. Effects of acute and chronic clozapine on dopamine release and metabolism in the striatum and nucleus accumbens of conscious rats.
Invernizzi R; Morali F; Pozzi L; Samanin R
Br J Pharmacol; 1990 Aug; 100(4):774-8. PubMed ID: 2207499
[TBL] [Abstract][Full Text] [Related]
19. Changes in striatal dopamine release and metabolism during and after subchronic haloperidol administration in rats.
See RE; Murray CE
Neurosci Lett; 1992 Aug; 142(1):100-4. PubMed ID: 1383895
[TBL] [Abstract][Full Text] [Related]
20. Biochemical and electrophysiological effects of 7-OH-DPAT on the mesolimbic dopaminergic system.
Devoto P; Collu M; Muntoni AL; Pistis M; Serra G; Gessa GL; Diana M
Synapse; 1995 Jun; 20(2):153-5. PubMed ID: 7570345
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
